Brain Glioma Registry Combining Clinical and Imaging Information

Summary

This registry aims to collect clinical and radiologic information including detailed clinical, conventional MR and advanced MR imaging data of patients with brain gliomas. Advanced MR imaging may include diffusion-weighted imaging, perfusion-weighted imaging (dynamic susceptibility contrast, arterial spin labeling, dynamic contrast enhancement), and chemical exchange saturation transfer (CEST) imaging. This registry will describe course of disease and long-term outcomes of brain gliomas.

Eligibility

Inclusion Criteria:

* Patients must have radiologically and histologically confirmed diagnosis of Brain Glioma
* Life expectancy of greater than 3 months
* Must receive a first- or second-line therapy
* Signed informed consent

Exclusion Criteria:

* No brain gliomas
* Patients who have any type of bioimplant activated by mechanical, electronic, or magnetic means (e.g., cochlear implants, pacemakers, neurostimulators, biostimulates, electronic infusion pumps, etc), because such devices may be displaced or malfunction
* Patients who are pregnant or breast feeding; urine pregnancy test will be performed on women of child bearing potential

Conditions2

Browse More Trials